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Background: Lacking enzymes for sterol synthesis, the intracellular protozoan Toxoplasma gondii scavenges
cholesterol from host cells to multiply. T. gondii has a complex life cycle consisting of two asexual stages; the
proliferative stage (tachyzoite), and the latent stage characterized by tissue cysts (bradyzoite). In vitro, bradyzoite
development can be induced by mimicking host immune response stressors through treatment with IFN-γ, heat
shock, nitric oxide, and high pH. However, the extent to which host nutrients contribute to stage conversion in
T. gondii is unknown. In this study, we examined the impact of host cholesterol levels on stage conversion in this
parasite.
Methods: Growth of T. gondii tachyzoites (ME49 strain) was investigated in Chinese hamster ovary (CHO) cells using
various concentrations of low-density lipoprotein (LDL), oleic acid, or glucose. Squalestatin, which is an inhibitor of
squalene synthase and is, therefore, an inhibitor of sterol synthesis, was used to treat the CHO cells. Tachyzoite to
bradyzoite conversion rates were analyzed by indirect fluorescent antibody tests.
Results: Parasite growth was significantly enhanced by addition of exogenous LDL, whereas no such enhancement
occurred with oleic acids or glucose. In ME49, growth inhibition from squalestatin treatment was not obvious.
Although growth of the RH strain was unaffected by squalestatin in the presence of lipoprotein, in its absence growth
of this strain was suppressed. The frequency of BAG1-positive vacuoles in ME49 increased under lipoprotein-free
conditions. However, addition of exogenous LDL did not increase tachyzoite to bradyzoite conversion in this strain.
Furthermore, treatment with squalestatin did not enhance stage conversion.
Conclusion: Our results suggest that LDL-derived cholesterol levels play a crucial role in bradyzoite conversion in
T. gondii.
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The obligate intracellular parasite Toxoplasma gondii
replicates inside a host cell in a specialized nonfusogenic
vacuole known as the parasitophorous vacuole (PV) [1].
Successful replication of T. gondii within the PV requires
considerable amounts of the specific lipids needed for
membrane biogenesis. T. gondii autonomously synthe-
sizes phospholipids, but can also readily scavenge lipid
precursors from host cells [2,3]. Previously, T. gondii was* Correspondence: nisikawa@obihiro.ac.jp
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article, unless otherwise stated.shown to be auxotrophic for low-density lipoprotein
(LDL)-derived cholesterol and that interfering with host
cholesterol acquisition by T. gondii impairs its growth
[4]. Although T. gondii cannot synthesize sterol, sterol
esterification has nevertheless been detected in this
parasite [5]. Cholesterol ester (CE) synthetic enzymes,
CE synthesis [2,5], and acyl-CoA: cholesterol acyltrans-
ferase (ACAT) enzymatic activity have been described in
T. gondii [5]. Regarding other esterification reactions in
T. gondii, one study indicated that triacylglycerol (TAG)
formation in this parasite occurs through an acyl-CoA:Central Ltd. This is an Open Access article distributed under the terms of the
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way [6]. T. gondii can acquire lipids from the host and
modify them to TAG and CE by TgDGAT1 and TgA-
CAT1, respectively, resulting in the formation of lipid
bodies in the parasite [5,6]. Furthermore, T. gondii infec-
tion triggers lipid body accumulation in host cells [7,8].
Toxoplasma disseminates within a host primarily through
interconversion between two asexual stages, tachyzoites
and bradyzoites. Differentiation of fast-replicating tachy-
zoites into dormant bradyzoite-stage parasites is pivotal to
tissue cyst formation, which allows life-long persistence of
viable parasites in the host. Tissue cysts containing bra-
dyzoites are found in many host organs, but appear to
preferentially develop in neural and muscular tissue [9].
The early events of parasite stage conversion are thought
to be of critical importance, where expression of tachy-
zoite-specific genes is switched off and bradyzoite-specific
genes are upregulated [10]. In vitro methods that stimulate
tachyzoite to bradyzoite interconversion are well-estab-
lished. Bradyzoite development can be induced by mim-
icking the stress of the host immune response through
treatment with interferon-gamma (IFN-γ), high tempe-
rature (43°C), nitric oxide, high pH (pH = 8.1), and/or
mitochondrial inhibitors [11-15]. Additionally, specific
organ or cell factors can trigger high levels of stage con-
version and tissue cyst formation [16]. Although T. gondii
has a highly clonal population structure comprising three
wide-spread and similar lineages, referred to as types I, II
and III, representative strains of these clonal lineages show
equal ability to differentiate into bradyzoites in vitro, with
the exception of the RH strain (type I) [17,18]. However,
the contribution that host cholesterol metabolism makes
to T. gondii stage conversion is unknown. Therefore, we
hypothesized that impairing host cholesterol levels would
induce bradyzoite conversion and affect parasite survival.
In the present study, to confirm this hypothesis, we exa-
mined the effects of host cholesterol on intracellular
growth and bradyzoite conversion in T. gondii.
Methods
Parasites and cell cultures
The Toxoplasma gondii RH and ME49 strains used in
this study were maintained in human foreskin fibro-
blast (HFF) cells cultured in Dulbecco’s modified Eagle
medium (DMEM, Sigma, St. Louis, MO) supplemented
with 10% heat-inactivated fetal bovine serum (FBS).
Chinese hamster ovary (CHO) cells were cultured in
Ham’s F-12 medium (Gibco BRL, Grand Island, NY)
supplemented with 10% heat-inactivated FBS. To purify
tachyzoites, the parasites and host-cell debris were
washed with cold PBS, and the final pellets were resus-
pended in cold medium and then passed through a
27-gauge needle and a 5.0-μm-pore filter (Millipore,
Bedford, MA).Reagents
Squalestatin and oleic acid were obtained from Sigma
(St. Louis, MO). Human LDL (density 1.019–1.063 g/mL)
was purchased from Biomedical Technologies Inc.
(Stoughton, MA). Lipoprotein-deficient serum (LPDS)
was prepared by ultracentrifugation of FBS after its
density was increased to 1.215 g/mL with potassium
bromide [4]. The cholesterol concentration in the
LPDS was estimated to be under the minimum level
detectable by a commercial detection kit (Cholesterol
E-test Wako, Wako Pure Chemical Industries).Parasite growth analyses
CHO cells (1 × 106) infected with T. gondii tachyzoites
(5 × 104) were cultured in 0.5 mL of medium in
24-well plates. After incubation for 44 h at 37°C,
[5,6-3H] uracil (Moravek Biochemicals, Brea, CA) was
added to the plates at 1 μCi/well and the cell mix-
tures were incubated for a further 2 h at 37°C. After
fixation with 10% trichloroacetic acid for 30 min, the
cell mixtures were incubated with 0.2 N NaOH for
30 min at 37°C. Radioactivity incorporated into the
parasites was measured using a beta counter (Perkin-
Elmer, Boston, MA).Indirect fluorescent antibody test (IFAT)
Parasite conversion was investigated using coverslips
with confluent CHO or HFF cells infected with the
ME49 strain of T. gondii. The coverslips were collected
72 h after parasite inoculation, washed twice with PBS
containing 1 mM CaCl2 and 1 mM MgCl2 (PBS++) and
then fixed with 3% paraformaldehyde in PBS++. After
washing twice with PBS++, the cells were perme-
abilized with 0.3% Triton X-100 in PBS++ for 5 min at
room temperature. After washing, the coverslips were
incubated with 3% bovine serum albumin (BSA) in
PBS++ at room temperature for 30 min. The coverslips
were incubated with BAG1 rabbit anti-serum and an
anti-SAG1 mouse monoclonal antibody (clone TP3;
Advanced ImmunoChemical Inc., Long Beach, CA) di-
luted at 1:100 in 3% BSA in PBS++ for 1 h at room
temperature. After washing three times with PBS++,
the coverslips were incubated with Alexa Fluor 488-
conjugated goat anti-rabbit IgG and Alexa Fluor 594-
conjugated goat anti-mouse IgG (Sigma, St. Louis,
MO) diluted at 1:1000 in 3% BSA in PBS++ for 1 h at
room temperature and then washed again with PBS++.
The coverslips were placed on a glass slide coated
with Mowiol (Calbiochem, San Diego, CA), and the
slides were examined using a fluorescence microscope
(Nikon, Tokyo, Japan). A total of 100 infected cells
were counted and the percentage of BAG1-positive
vacuoles was determined.
Figure 2 Squalestatin treatment and parasite growth. Uracil
incorporation was assayed using CHO cells infected with the ME49
strain (A) or RH strain (B) of T. gondii for 44 h in medium containing
5% LPDS or 5% FBS treated with squalestatin at the concentrations
indicated. Data are expressed as a percentage relative to that of the
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Growth differences associated with LDL, fatty acids, and
glucose
To investigate the factors important for parasite growth,
we investigated the growth of T. gondii tachyzoites
(ME49 strain) in CHO cells (Figure 1). Under lipopro-
tein free conditions, parasite growth was significantly
enhanced by exogenous LDL (Figure 1A). However, nei-
ther exogenous oleic acids nor glucose stimulated para-
site growth (Figure 1A, B).
Effect of host cholesterol on parasite growth
We focused on the effect of host cholesterol levels on
T. gondii growth in CHO cells because cholesterol is one
of the major components of LDL (Figure 1). No significant
differences were observed when the parasites were grown
in medium containing 5% FBS or 5% LPDS (Figure 2).
Squalestatin, which is a squalene synthase inhibitor and is,
therefore, an inhibitor of sterol synthesis, was used to in-
hibit cholesterol synthesis in CHO cells. Growth inhibition
of ME49 by squalestatin was not obvious in medium con-
taining 5% FBS or 5% LPDS (Figure 2A). However, in
medium containing 5% FBS, squalestatin treatment did
not affect the growth of the RH strain, while the growth of
this strain was suppressed by squalestatin treatment inFigure 1 Parasite growth in the presence of LDL, fatty acids, or
glucose. Uracil incorporation was assayed using CHO cells infected
with the ME49 strain of T. gondii for 20 h in medium containing 5%
LPDS treated with LDL or oleic acid at the concentrations indicated
(A), or in glucose-free medium containing 10% FBS treated with
glucose at the concentrations indicated (B). Data are expressed as a
percentage relative to the control (incubation without lipid or
glucose), which was taken as 100% ± the standard deviation (n = 4).
control (incubation in the presence of 5% LPDS without squalestatin),
which was taken as 100%± the standard deviation of triplicate samples.
Statistical analysis of the data was conducted using a one-way ANOVA
followed by Tukey’s multiple comparison tests. (*) Values of P < 0.01
were considered statistically significant when compared with
incubation without squalestatin.medium containing 5% LPDS (Figure 2B). This result indi-
cates that host cholesterol starvation affected growth in
the RH strain.
Effect of host cholesterol starvation on bradyzoite
conversion
Because the ME49 strain was resistant to host-cholesterol
starvation in CHO cells, we speculated that variations in
host cholesterol levels would influence bradyzoite conver-
sion. To investigate whether host cholesterol induced
tachyzoite to bradyzoite stage-conversion in T. gondii,
IFAT analyses were performed using the bradyzoite-
specific marker, BAG1, and tachyzoite specific marker,
SAG1 (Figure 3). The frequency of BAG1 expression in
the parasites increased in medium containing 5% LPDS
compared with medium containing 5% FBS. However,
addition of exogenous LDL did not enhance bradyzoite
conversion in medium containing 5% LPDS. Furthermore,
treatment with squalestatin did not enhance stage con-
version in medium containing 5% LPDS or 5% FBS. These
results indicate that low levels of LDL-derived host choles-
terol trigger bradyzoite conversion.
Figure 3 IFAT analysis of BAG1 expression in parasite vacuoles. CHO cells were infected with T. gondii ME49. After 72 h, the parasite-infected
cells were subjected to IFAT analyses. (A) Infected CHO cells were stained with a SAG1 antibody (tachyzoite specific marker) and a BAG1 antibody
(bradyzoite specific marker). Scale bar: 10 μm. (B) Percentage of vacuoles expressing BAG1. Data represent the mean percentage of BAG-positive
vacuoles from one hundred vacuoles (from triplicate samples). Statistical analysis of the data was conducted using a one-way ANOVA followed by
Tukey’s multiple comparison tests. Different symbols indicate statistically significant differences (P < 0.01). SS, 50 μM squalestatin.
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Developmental stage conversion in T. gondii is a compli-
cated process. Tachyzoite to bradyzoite transformation
has been shown in vitro through induction of stress by
host cell treatment with IFN-γ or mitochondrial inhibitors
[11,12], alkaline pH, or high temperature [14,16]. Thus,
exogenous stressors appear to influence the develop-
mental differentiation of T. gondii. In this study, we
investigated how host cholesterol levels affected stage
conversion in T. gondii. Suppression of parasite growth is
important for bradyzoite conversion [12]. Here, LDL-
derived host cholesterol was one nutrient found to be
involved in T. gondii growth, while glucose and fatty acids
(oleic acids) did not affect parasite growth. Although
inhibition of host cholesterol synthesis and uptake re-
sulted in strong growth inhibition in RH, growth of the
ME49 strain was only partially suppressed. Importantly,
we showed that lower levels of LDL-derived host choles-
terol induced bradyzoite conversion of the ME49 strain in
CHO cells. This observation was also confirmed in HFF
cells (data not shown). While there was no significant
difference in parasite growth after 44 h of incubation in
medium containing LPDS or FBS, BAG1 expression levels
increased after 72 h incubation in LPDS. These results
suggest that a gradual reduction in parasite growth oc-
curred following BAG1 expression. Our findings are note-
worthy because they suggest that starvation of specific
nutrients is a trigger for parasite stage conversion. The
ME49 strain may adjust to host cholesterol starvation by
converting into quiescent encysted bradyzoites to reduce
its cholesterol consumption. Because the RH strain is con-
sidered to be less cystogenic than the ME49 strain, lack ofthis nutrient may be lethal to this parasite. These data sug-
gest different cholesterol metabolism exists between RH
and ME49 strains.
Although tissue cysts containing T. gondii bradyzoites
are found in multiple organs of the host, there appears
to be preferential development of the cysts within mus-
cular and neural tissue [19], suggesting that host cell
type plays a role in this process. Primary skeletal muscle
cells trigger bradyzoite conversion in the absence of ex-
ogenous stress factors [16]. Similarly, the RH strain can
also differentiate spontaneously into bradyzoites in pri-
mary skeletal muscle cells [20]. In addition, T. gondii
tachyzoite infection of skeletal muscle cells led to an in-
crease in lipid droplet numbers [8]. The lipid droplets
were in direct contact with the PV membrane, indicating
that the lipid droplets were recruited for delivery inside
the PV in T. gondii-infected skeletal muscle cells [8].
These results suggest that lipoprotein uptake by skeletal
muscle cells plays a role in parasite stage conversion. In
the central nervous system, cholesterol production by
glial cells and its delivery via apoE-containing lipo-
protein plays a crucial role in brain function [21]. In-
deed, massive synaptogenesis requires large amounts of
cholesterol [22]. After neural cells are infected with
T. gondii, the parasite may compete with the host cell
for cholesterol acquisition, resulting in tachyzoite to bra-
dyzoite conversion.
Conclusions
Our results indicate that T. gondii utilizes host choles-
terol derived from LDL in CHO cells and that bradyzoite
conversion occurs in the absence of LDL in these cells.
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host cell type plays a role in LDL-mediated stage conver-
sion in T. gondii. Hence, it is important to consider the
contribution that host cell factor(s) play in stage conver-
sion. Elucidation of the molecular mechanisms under-
lying cholesterol metabolism in parasite stage conversion
in different host cell types forms the basis of our future
studies.
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